ABSTRACT. Premature rabbit neonates delivered at gestational age 27 days were ventilated by high frequency oscillation for 60 min with 100% 02, using a frequency of 7-8 Hz, 50% inspiration time and mean airway pressures of 6-8 cm H20. Twenty-five animals received bovine surfactant (2 ml/kg body weight; phospholipid concentration 85-100 mg/ml) in the tracheal cannula before onset of ventilation, and 22 littermates served as controls. In the surfactant-treated group, average tidal volume was about 10 times larger than in controls, yet only 15% of the estimated dead space. Judged from ECG recordings, the treated animals also had a much higher survival rate: 96 versus 5% (p < 0.001). Morphometrically, mean alveolar volume density was increased in the surfactant-treated animals in comparison with controls: 0.65 f 0.08 versus 0.37 + 0.08 (2 f SD; p < 0.005). Bronchiolar epithelial lesions were found in all control animals and were severe in almost all cases. In the surfactant-treated group, epithelial lesions were absent in 12, mild in 11, and fairly prominent in two animals. We conclude that after treatment with surfactant, the premature newborn rabbit can be ventilated adequately with high frequency oscillation at comparatively low mean airway pressures and that surfactant replacement effectively reduces the development of epithelial lesions in conducting airways during high frequency oscillation. (Pediatr Res 19: 143-147, 1985) Abbreviations HFO, high frequency oscillation VT, tidal volume VV, volume density
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The tendency of the surfactant-deficient lung to collapse at end-expiration can be compensated for by a variety of therapeutic measures, such as the application of continuous positive airway pressure (3) or the adjustment of respiratory rate and inspiration/ expiration ratio during artificial ventilation (6) (1 2).
Ventilation of surfactant-deficient lungs with HFO might increase the risk of air leakage and pneumothorax if high mean airway pressure levels are required to prevent alveolar collapse (9) . We have approached this problem by evaluating the combined effect of surfactant replacement and HFO in prematurely delivered newborn rabbits. In particular, we were interested in whether treatment with surfactant would improve survival and prevent the development of epithelial lesions during HFO, i.e.
whether surfactant replacement would be as effective during HFO as during conventional positive pressure ventilation (10) .
MATERIALS AND METHODS
Preparation of animals: surfactant replacement. We used 47 premature rabbit neonates delivered from seven does on day 27 of gestation (term = 3 1 days). The animals were obtained by hysterotomy during general anesthesia with sodium pentobarbital (Mebumal vet., 60 mg/ml, ACO, Solna, Sweden). Immediately after birth, the neonates received an intraperitoneal injection of 0.1 ml sodium pentobarbital (Mebumal vet., 60 mg/ml, diluted 1:lO). They were then tracheotomized in sequence, and in alternate animals a suspension of natural surfactant (2 ml/kg body weight; phospholipid concentration 85-100 mg/ml) was given in the tracheal cannula. In littermate controls the tracheal cannula was empty. Body weights (x + SD) of surfactant-treated animals and controls were 28 5 4 and 27 + 3 g, respectively.
Surfactant for these experiments was prepared from minced cow lungs by centrifugation (3000 x g, 4" C, 2 h), extraction with chloroform/methanol 2: 1 (v/v), and liquid-gel chromatography (Lipidex-5000). This procedure results in separation of the surfactant lipids into phospholipids, cholesterol, triglycerides, and cholesterylesters. The phospholipid fraction (which also contains approximately 1 % protein) was used in the present experiment; its composition is shown in Table 1 .
Ventilation. After tracheotomy, the animals were kept at 37" C in a multichambered, pressure-constant body-plethysmograph system (6) . Before the onset of artificial ventilation, the plethysmographs were flushed with 100% 0' and the neonates were allowed to breathe spontaneously. When the whole litter had been tracheotomized (duration of the tracheotomy procedure: 2-3 minianimal) each neonate received an intraperitoneal injection of 0.1 ml pancuronium bromide (Pavulon, 2 mg/ml, Organon, Oss, Holland, diluted 1 : 10). The animals were then ventilated in parallel for 60 min with 100% 0'. First, they were subjected for 30 s to conventional artificial ventilation (Servo Ventilator 900B, Siemens-Elema, Solnn, Sweden) with an insumation pressure of 35 cm H20, a frequency of 40/min, and 50% inspiration time, to promote uniform distribution of the exogenous surfactant within the lungs. Then the lungs were inflated for 30 s with a static pressure of 30 cm H20. The pressure was then lowered to 6-8 cm H20, and the animals were connected to a HFO unit (Siemens-Elema) generating a square pressure wave with frequency 15 Hz and 50% inspiration time at gas flow 2.5 literlmin. Insumation pressure was recorded continuously with a pressure transducer (EMT 34, Siemens-Elema), VT with a differential pressure trans- ducer (EMT 32, Siemens-Elema) connected to the plethysmograph via a specially designed Fleisch tube (7) . Tracings of insumation pressure, VT, and ECG were obtained on a Mingograf 8 1 (Siemens-Elema). VT of individual animals was defined as the mean of a randomly selected sequence of 10 volume oscillations.
Recordings < 0.00 1 ml were counted as 0 in our statistics.
In five litters, recordings of VT indicated gradual lung collapse in some (n = 6) of the surfactant-treated animals that had initially exhibited satisfactory volume oscillations (about 0.3 ml/kg). HFO was then interrupted and a static insumation pressure of 25 cm H 2 0 applied to all animals for 15 s. After this "sigh," HFO was reestablished at the same mean airway pressure as before. The sigh maneuvre had to be repeated one to nine times to obtain a steady state.
Although a frequency of 15 Hz was generated by the ventilator unit, recordings of pressure and VT indicated that the lungs of the animals were, in fact, oscillating at a frequency of only 7-8 Hz. This discrepancy was caused by inertia in the water-seal used to maintain continuous distending airway pressure. Euring HFO, pressure in the ventilator system varied by 1-2 cm H 2 0 above and below the mean pressure level.
Histologic and morphometric techniques. After the experiment, the animals were killed by an intraperitoneal injection of Mebumal vet. (0.5 ml). The abdomen of each animal was incised and the diaphragms inspected for evidence of pneumothorax. The chest was opened and a cannula was inserted into the pulmonary artery. The lungs were inflated with a pressure of 30 cm H20 for 30 s. The endotracheal pressure was then lowered and maintained at 10 cm H 2 0 for 15 min, while the pulmonary artery was perfused with a mixture of 1 % glutaraldehyde and 3.5% formaldehyde at a pressure of 70 cm H20. After perfusion, the lungs were removed and kept in 10% formalin for at least 24 h. Paraffin sections from the basal parts of both lungs were stained with hematoxylin and eosin and examined microscopically. The relative volume of the alveolar spaces, the alveolar Vv, was determined by point-counting. The same sections were reexamined at high power for evidence of bronchiolar epithelial lesions.
Statistical evaluation. The x ' test and the Wilcoxon two-
sample test (two-tailed) were used in our statistical calculations.
RESULTS

Survival. According to ECG recordings, only one of the 22
control animals survived the period of ventilation. By contrast, 23 of 24 surfactant-treated neonates (ECG could not be recorded in one animal) had regular cardiac activity at the end of the experiment ( p < 0.00 1; Fig. 1 ). Cardiac frequency of surviving surfactant-treated animals was 2 17 5 40/min (2 + SD).
V , At all intervals, VT was significantly higher in surfactanttreated animals than in controls (Fig. 1, Table 2 ). This was also obvious from direct inspection: the chest of most surfactanttreated animals vibrated vigorously while the controls exhibited no visible movements. Average VT in surfactant-treated animals was about 15% of the estimated dead space, 2.2 ml/kg (13) .
Complications. Postmortem examination revealed pneumothorax in two surfactant-treated animals; no such complication was observed in controls.
Histologic and morphometricfindings. The lungs of surfactanttreated animals were generally well expanded and contained only small amounts of fluid in the alveolar spaces. The rounded configuration of alveoli indicated that they were air-expan.jed ( Fig. 2A) . In control animals, the lungs were largely collapsed with wrinkled, fluid-filled alveoli (Fig. 2B) . Alveolar Vv was significantly higher in surfactant-treated animals than in controls (Table 3) . Bronchiolar epithelial lesions were absent in 12 of the surfactant-treated animals (Fig. 3A) , mild in 11, and fairly prominent in two. The six animals that had to be "sighed" repeatedly to maintain satisfactory volume oscillation, and the two animals All but one of the control animals displayed extensive necrosis and desquamation of bronchiolar epithelium with abundant hyaline membranes (Fig. 3B, Table 3 ). In the remaining contro! similar, but less prominent, lesions were observed.
S u r f a c t a n t DISCUSSION 0.01rnl " I Judged from our recordings of in vivo lung mechanics and ECG, treatment with surfactant increases VT and survival in premature rabbit neonates ventilated with HFO. These benefits of surfactant replacement are similar to those previously documented in premature newborn rabbits during spontaneous (8) or artificial ventilation (10) . Our data are also in agreement with findings reported by Takada et al. (14) who found, in experiments on lung-lavaged adult rabbits, that the effects of surfactant nebulization during high frequency jet ventilation were equivalent to those of surfactant instillation during conventional positive pressure ventilation.
The mean airway pressure used in the present experiments, 6-8 cm H,O, was too low to ensure air expansion of the lungs in control animals, yet it was high enough to allow the development of bronchiolar epithelial lesions. Surfactant-treated animals ventilated with the same mean airway pressure had mostly wellexpanded lungs, with significantly less epithelial lesions. This suggests that the epithelial lesions do not result simply from "barotrauma," but from a disturbance of the normal expansion pattern of alveoli and bronchioles. Since the length and diameter of the bronchioles depend on the degree of expansion of sur- rounding alveoli (4), shear forces develop in a lung that is not uniformly expanded. These forces might lead to necrosis and desquamation of bronchiolar epithelium within a few minutes of spontaneous (2) or artificial ventilation (1 1). If surfactantdeficient lungs are subjected to HFO with a mean airway pressure that is too low to keep the alveoli open, the same pathogenic mechanism is triggered and epithelial lesions would tend to occur proximal to air-liquid interfaces "rattling" in terminal bronchioles. Treatment with surfactant probably protects against airway epithelial lesions by holding the air-liquid interface at alveolar level throughout the ventilatory cycle, and by promoting uniform alveolar expansion. The bronchioles are then stabilized by surrounding aerated alveoli. Some epithelial lesions were observed in all the six surfactant-treated animals that had to be "sighed" to avoid gradual lung collapse. These animals obviously needed a mean airway pressure higher than that required to maintain stable lung aeration in other surfactant-treated littermates. Individual adjustment of mean airway pressure (a prerequisite for adequate clinical management of patients with severe surfactant deficiency) was not feasible in the present system for "collective" artificial ventilation.
In these experiments, mean airway pressure was adjusted to maintain adequate oscillatory volume in surfactant-treated animals, whereas the lungs of control animals were oscillated in a nearly collapsed state. Our data do not provide evidence whether, in control animals, epithelial lesions would be less prominent if the alveoli had been kept open with a higher mean airway pressure. It may be concluded, however, that after treatment with exogenous surfactant, the premature rabbit lung can be ventilated adequately with HFO at a comparatively low mean airway pressure, and that at these particular experimental conditions surfactant replacement effectively prevents the development of epithelial lesions.
